Inflammatory bowel disease course in Crohn's disease: Is the natural history changing?

World Journal of Gastroenterology

Volumn 20, Issue 12, 2014, Pages 3198-3207

  Golovics, Petra A ^a   Mandel, Michael D ^a   Lovasz, Barbara D ^a   Lakatos, Peter L ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Crohn's disease; Disease course; Inflammatory bowel disease; Mortality; Natural history; Surgery

Indexed keywords

ARTICLE; BIOLOGICAL THERAPY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE COURSE; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY BOWEL DISEASE; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; PATIENT MONITORING; TREATMENT OUTCOME; TREATMENT PLANNING; ULCERATIVE COLITIS; COMPLICATION; INFLAMMATION; PATHOPHYSIOLOGY; PROGNOSIS; RISK FACTOR; STENOSIS, OCCLUSION AND OBSTRUCTION; TIME;

BIOLOGICAL PRODUCT; IMMUNOSUPPRESSIVE AGENT;

BIOLOGICAL PRODUCTS; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; DISEASE PROGRESSION; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; PROGNOSIS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84896977224     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i12.3198     Document Type: Article

References (65)

1. Lees CW, Barrett JC, Parkes M, Satsangi J. New IBD genetics: common pathways with other diseases. Gut 2011; 60: 1739-1753 [PMID: 21300624 DOI: 10.1136/gut.2009.199679]
2. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the Inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54.e42; quiz e30 [PMID: 22001864 DOI: 10.1053/j.gastro.2011.10.001]
3. Miheller P, Kiss LS, Juhasz M, Mandel M, Lakatos PL. Recommendations for identifying Crohn's disease patients with poor prognosis. Expert Rev Clin Immunol 2013; 9: 65-75; quiz 76 [PMID: 23256765 DOI: 10.1586/eci.12.86]
4. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus EV, Peña AS, Riddell RH, Sa-char DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF. Toward an integrated clinical, molecular and se-rological classification of Inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 Suppl A: 5A-36A [PMID: 16151544]
5. Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Ge-boes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, Van Assche G. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: defnitions and diagnosis. J Crohns Colitis 2012; 6: 965-990 [PMID: 23040452 DOI: 10.1016/ j.crohns.2012.09.003]
6. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP. Long-term evolution of disease behavior of Crohn's disease. Infamm Bowel Dis 2002; 8: 244-250 [PMID: 12131607 DOI: 10.1097/00054725-200207000-00002]
7. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yaf FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49: 777-782 [PMID: 11709511 DOI: 10.1136/gut.49.6.777]
8. Bernstein CN, Loftus EV, Ng SC, Lakatos PL, Moum B. Hos-pitalisations and surgery in Crohn's disease. Gut 2012; 61: 622-629 [PMID: 22267595 DOI: 10.1136/gutjnl-2011-301397]
9. Burisch J, Jess T, Martinato M, Lakatos PL. The burden of in-flammatory bowel disease in Europe. J Crohns Colitis 2013; 7: 322-337 [PMID: 23395397 DOI: 10.1016/j.crohns.2013.01.010]
10. Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010; 105: 289-297 [PMID: 19861953 DOI: 10.1038/ajg.2009.579]
11. Solberg IC, Vatn MH, Høie O, Stray N, Sauar J, Jahnsen J, Moum B, Lygren I. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 2007; 5: 1430-1438 [PMID: 18054751 DOI: 10.1016/j.cgh.2007.09.002]
12. Jess T, Riis L, Vind I, Winther KV, Borg S, Binder V, Lang-holz E, Thomsen OØ, Munkholm P. Changes in clinical characteristics, course, and prognosis of Inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007; 13: 481-489 [PMID: 17206705 DOI: 10.1002/ibd.20036]
13. Lakatos L, Kiss LS, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Lakatos PL. Incidence, disease phenotype at diagnosis, and early disease course in Inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis 2011; 17: 2558-2565 [PMID: 22072315 DOI: 10.1002/ibd.21607]
14. Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Lof-tus EV. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology 2010; 139: 1147-1155 [PMID: 20637205 DOI: 10.1053/j.gastro.2010.06.070]
15. Burisch J, Pedersen N, Cukovi-Cavka S, Brinar M, Kaimakliotis I, Duricova D, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Andersen V, Krabbe S, Dahlerup JF, Salu-pere R, Nielsen KR, Olsen J, Manninen P, Collin P, Tsianos EV, Katsanos KH, Ladefoged K, Lakatos L, Björnsson E, Ragnarsson G, Bailey Y, Odes S, Schwartz D, Martinato M, Lupinacci G, Milla M, De Padova A, D'Incà R, Beltrami M, Kupcinskas L, Kiudelis G, Turcan S, Tighineanu O, Mihu I, Magro F, Barros LF, Goldis A, Lazar D, Belousova E, Niku-lina I, Hernandez V, Martinez-Ares D, Almer S, Zhulina Y, Halfvarson J, Arebi N, Sebastian S, Lakatos PL, Langholz E, Munkholm P; for the EpiCom-group. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014; 63: 588-597 [PMID: 23604131 DOI: 10.1136/gutjnl-2013-304636]
16. Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH, Li MF, Ng KK, Kamm MA, Studd C, Bell S, Leong R, de Silva HJ, Kasturi-ratne A, Mufeena MN, Ling KL, Ooi CJ, Tan PS, Ong D, Goh KL, Hilmi I, Pisespongsa P, Manatsathit S, Rerknimitr R, Aniwan S, Wang YF, Ouyang Q, Zeng Z, Zhu Z, Chen MH, Hu PJ, Wu K, Wang X, Simadibrata M, Abdullah M, Wu JC, Sung JJ, Chan FK. Incidence and phenotype of Inflammatory bowel disease based on results from the Asia-paciflic Crohn' s and colitis epidemiology study. Gastroenterology 2013; 145: 158-165.e2 [PMID: 23583432 DOI: 10.1053/j.gastro.2013.04]
17. Tarrant KM, Barclay ML, Frampton CM, Gearry RB. Peri-anal disease predicts changes in Crohn's disease phenotype-results of a population-based study of Inflammatory bowel disease phenotype. Am J Gastroenterol 2008; 103: 3082-3093 [PMID: 19086959 DOI: 10.1111/j.1572-0241.2008.02212]
18. Lovasz BD, Lakatos L, Horvath A, Szita I, Pandur T, Man-del M, Vegh Z, Golovics PA, Mester G, Balogh M, Molnar C, Komaromi E, Kiss LS, Lakatos PL. Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort. World J Gastroenterol 2013; 19: 2217-2226 [PMID: 23599648 DOI: 10.3748/wjg.v19.i14.2217]
19. Tang LY, Rawsthorne P, Bernstein CN. Are perineal and luminal fistulas associated in Crohn's disease? A population-based study. Clin Gastroenterol Hepatol 2006; 4: 1130-1134 [PMID: 16905369]
20. Abraham BP, Mehta S, El-Serag HB. Natural history of pedi-atric-onset Inflammatory bowel disease: a systematic review. J Clin Gastroenterol 2012; 46: 581-589 [PMID: 22772738 DOI: 10.1097/MCG.0b013e318247c32f]
21. Pigneur B, Seksik P, Viola S, Viala J, Beaugerie L, Girardet JP, Ruemmele FM, Cosnes J. Natural history of Crohn's disease: comparison between childhood- and adult-onset disease. Infamm Bowel Dis 2010; 16: 953-961 [PMID: 19834970 DOI: 10.1002/ibd.21152]
22. de Bie CI, Paerregaard A, Kolacek S, Ruemmele FM, Ko-letzko S, Fell JM, Escher JC. Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EU-ROKIDS Registry. Infamm Bowel Dis 2013; 19: 378-385 [PMID: 22573581 DOI: 10.1002/ibd.23008]
23. Levine A. Pediatric inflammatory bowel disease: is it different? Dig Dis 2009; 27: 212-214 [PMID: 19786743 DOI: 10.1159/000228552]
24. Van Limbergen J, Russell RK, Drummond HE, Aldhous MC, Round NK, Nimmo ER, Smith L, Gillett PM, McGrogan P, Weaver LT, Bisset WM, Mahdi G, Arnott ID, Satsangi J, Wilson DC. Definition of phenotypic characteristics of childhood-onset Inflammatory bowel disease. Gastroenterol-ogy 2008; 135: 1114-1122 [PMID: 18725221 DOI: 10.1053/ j.gastro.2008.06.081]
25. Vernier-Massouille G, Balde M, Salleron J, Turck D, Dupas JL, Mouterde O, Merle V, Salomez JL, Branche J, Marti R, Le-rebours E, Cortot A, Gower-Rousseau C, Colombel JF. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 2008; 135: 1106-1113 [PMID: 18692056 DOI: 10.1053/j.gastro.2008.06.079]
26. Israeli E, Ryan JD, Shafer LA, Bernstein CN. Younger age at diagnosis is associated with panenteric, but not more aggressive, Crohn's disease. Clin Gastroenterol Hepatol 2014; 12: 72-79.e1 [PMID: 23880115 DOI: 10.1016/j.cgh.2013.06.027]
27. Gower-Rousseau C, Vasseur F, Fumery M, Savoye G, Sal-leron J, Dauchet L, Turck D, Cortot A, Peyrin-Biroulet L, Colombel JF. Epidemiology of Inflammatory bowel diseases: new insights from a French population-based registry (EPI-MAD). Dig Liver Dis 2013; 45: 89-94 [PMID: 23107487 DOI: 10.1016/j.dld.2012.09.005]
28. Charpentier C, Salleron J, Savoye G, Fumery M, Merle V, Laberenne JE, Vasseur F, Dupas JL, Cortot A, Dauchet L, Peyrin-Biroulet L, Lerebours E, Colombel JF, Gower-Rous-seau C. Natural history of elderly-onset Inflammatory bowel disease: a population-based cohort study. Gut 2014; 63: 423-432 [PMID: 23408350 DOI: 10.1136/gutjnl-2012-303864]
29. Lakatos PL, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Kiss LS, Lakatos L. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. J Crohns Colitis 2011; 5: 5-13 [PMID: 21272797 DOI: 10.1016/j.crohns.2010.08.004]
30. Binder V, Hendriksen C, Kreiner S. Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen. Gut 1985; 26: 146-150 [PMID: 3967832]
31. Wolters FL, Russel MG, Sijbrandij J, Ambergen T, Odes S, Riis L, Langholz E, Politi P, Qasim A, Koutroubakis I, Tsia-nos E, Vermeire S, Freitas J, van Zeijl G, Hoie O, Bernklev T, Beltrami M, Rodriguez D, Stockbrügger RW, Moum B. Phenotype at diagnosis predicts recurrence rates in Crohn' s disease. Gut 2006; 55: 1124-1130 [PMID: 16361306 DOI: 10.1136/gut.2005.084061]
32. van der Valk ME, Mangen MJ, Leenders M, Dijkstra G, van Bodegraven AA, Fidder HH, de Jong DJ, Pierik M, van der Woude CJ, Romberg-Camps MJ, Clemens CH, Jansen JM, Mahmmod N, van de Meeberg PC, van der Meulen-de Jong AE, Ponsioen CY, Bolwerk CJ, Vermeijden JR, Siersema PD, van Oijen MG, Oldenburg B. Healthcare costs of infamma-tory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study. Gut 2014; 63: 72-79 [PMID: 23135759 DOI: 10.1136/ gutjnl-2012-303376]
33. Munkholm P, Langholz E, Davidsen M, Binder V. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995; 30: 699-706 [PMID: 7481535]
34. Odes S, Vardi H, Friger M, Wolters F, Russel MG, Riis L, Munkholm P, Politi P, Tsianos E, Clofent J, Vermeire S, Mon-teiro E, Mouzas I, Fornaciari G, Sijbrandij J, Limonard C, Van Zeijl G, O'morain C, Moum B, Vatn M, Stockbrugger R. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 2006; 131: 719-728 [PMID: 16952541 DOI: 10.1053/j.gastro.2006.05.052]
35. Bernstein CN, Nabalamba A. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study. Am J Gastroenterol 2006; 101: 110-118 [PMID: 16405542 DOI: 10.1111/j.1572-0241.2006.00330.x]
36. Nguyen GC, Nugent Z, Shaw S, Bernstein CN. Outcomes of patients with Crohn's disease improved from 1988 to 2008 and were associated with increased specialist care. Gastro-enterology 2011; 141: 90-97 [PMID: 21458455 DOI: 10.1053/ j.gastro.2011.03.050]
37. Sonnenberg A. Age distribution of IBD hospitalization. Inflamm Bowel Dis 2010; 16: 452-457 [PMID: 19714765 DOI: 10.1002/ibd.21058]
38. Bewtra M, Su C, Lewis JD. Trends in hospitalization rates for inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol 2007; 5: 597-601 [PMID: 17382602]
39. Sonnenberg A. Hospitalization for Inflammatory bowel disease in the United States between 1970 and 2004. J Clin Gas-troenterol 2009; 43: 297-300 [PMID: 18936713 DOI: 10.1097/ MCG.0b013e31816244a0]
40. Nguyen GC, Tuskey A, Dassopoulos T, Harris ML, Brant SR. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Infamm Bowel Dis 2007; 13: 1529-1535 [PMID: 17828784 DOI: 10.1002/ ibd.20250]
41. Herrinton LJ, Liu L, Fireman B, Lewis JD, Allison JE, Flowers N, Hutfless S, Velayos FS, Abramson O, Altschuler A, Perry GS. Time trends in therapies and outcomes for adult Inflammatory bowel disease, Northern California, 1998-2005. Gastroenterology 2009; 137: 502-511 [PMID: 19445944 DOI: 10.1053/j.gastro.2009.04.063]
42. Wolters FL, Russel MG, Stockbrügger RW. Systematic review: has disease outcome in Crohn's disease changed during the last four decades? Aliment Pharmacol Ther 2004; 20: 483-496 [PMID: 15339320 DOI: 10.1111/j.1365-2036.2004.02123.x]
43. Hellers G. Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. Acta Chir Scand Suppl 1979; 490: 1-84 [PMID: 293116]
44. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000; 231: 38-45 [PMID: 10636100]
45. Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993; 105: 1716-1723 [PMID: 8253348]
46. Ye BD, Yang SK, Cho YK, Park SH, Yang DH, Yoon SM, Kim KJ, Byeon JS, Myung SJ, Yu CS, Kim JH. Clinical features and long-term prognosis of Crohn's disease in Korea. Scand J Gastroenterol 2010; 45: 1178-1185 [PMID: 20560811 DOI: 10.3109/00365521.2010.497936]
47. Oriuchi T, Hiwatashi N, Kinouchi Y, Takahashi S, Takagi S, Negoro K, Shimosegawa T. Clinical course and long-term prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality. J Gas-troenterol 2003; 38: 942-953 [PMID: 14614601 DOI: 10.1007/ s00535-003-1177-9]
48. Rungoe C, Langholz E, Andersson M, Basit S, Nielsen NM, Wohlfahrt J, Jess T. Changes in medical treatment and surgery rates in Inflammatory bowel disease: a nationwide cohort study 1979-2011. Gut 2013; Epub ahead of print [PMID: 24056767 DOI: 10.1136/gutjnl-2013-305607]
49. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosup-pressants in Crohn's disease on the need for intestinal surgery. Gut 2005; 54: 237-241 [PMID: 15647188 DOI: 10.1136/ gut.2004.045294]
50. Lakatos PL, Golovics PA, David G, Pandur T, Erdelyi Z, Horvath A, Mester G, Balogh M, Szipocs I, Molnar C, Koma-romi E, Veres G, Lovasz BD, Szathmari M, Kiss LS, Lakatos L. Has there been a change in the natural history of Crohn' s disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. Am J Gastroenterol 2012; 107: 579-588 [PMID: 22233693 DOI: 10.1038/ajg.2011.448]
51. Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 2010; 59: 1200-1206 [PMID: 20650924 DOI: 10.1136/ gut.2009.202101]
52. Peyrin-Biroulet L, Oussalah A, Williet N, Pillot C, Bresler L, Bigard MA. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease. Gut 2011; 60: 930-936 [PMID: 21228429 DOI: 10.1136/gut.2010.227884]
53. Cosnes J, Bourrier A, Laharie D, Nahon S, Bouhnik Y, Car-bonnel F, Allez M, Dupas JL, Reimund JM, Savoye G, Jouet P, Moreau J, Mary JY, Colombel JF. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. Gastroenterology 2013; 145: 758-765.e2; quiz e14-15 [PMID: 23644079 DOI: 10.1053/ j.gastro.2013.04.048]
54. Panés J, López-Sanromán A, Bermejo F, García-Sánchez V, Esteve M, Torres Y, Domènech E, Piqueras M, Gomez-García M, Gutiérrez A, Taxonera C, Sans M. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease. Gastroenterology 2013; 145: 766-774.e1 [PMID: 23770132 DOI: 10.1053/j.gastro.2013.06.009]
55. Aratari A, Papi C, Leandro G, Viscido A, Capurso L, Caprilli R. Early versus late surgery for ileo-caecal Crohn's disease. Aliment Pharmacol Ther 2007; 26: 1303-1312 [PMID: 17848181 DOI: 10.1111/j.1365-2036.2007.03515.x]
56. Latella G, Cocco A, Angelucci E, Viscido A, Bacci S, Neco-zione S, Caprilli R. Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen. Dig Liver Dis 2009; 41: 269-276 [PMID: 18955023 DOI: 10.1016/j.dld.2008.09.010]
57. Golovics PA, Lakatos L, Nagy A, Pandur T, Szita I, Balogh M, Molnar C, Komaromi E, Lovasz BD, Mandel M, Veres G, Kiss LS, Vegh Z, Lakatos PL. Is early limited surgery associated with a more benign disease course in Crohn's disease? World J Gastroenterol 2013; 19: 7701-7710 [PMID: 24282358 DOI: 10.3748/wjg.v19.i43.7701]
58. Duricova D, Pedersen N, Elkjaer M, Gamborg M, Munkholm P, Jess T. Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies. Inflamm Bowel Dis 2010; 16: 347-353 [PMID: 19572377 DOI: 10.1002/ibd.21007]
59. Jess T, Frisch M, Simonsen J. Trends in overall and cause-specific mortality among patients with Inflammatory bowel disease from 1982 to 2010. Clin Gastroenterol Hepatol 2013; 11: 43-48 [PMID: 23022699 DOI: 10.1016/j.cgh.2012.09.026]
60. Canavan C, Abrams KR, Mayberry JF. Meta-analysis: mortality in Crohn's disease. Aliment Pharmacol Ther 2007; 25: 861-870 [PMID: 17402989 DOI: 10.1111/j.1365-2036.2007.03276.x]
61. Manninen P, Karvonen AL, Huhtala H, Rasmussen M, Salo M, Mustaniemi L, Pirttiniemi I, Collin P. Mortality in ulcer-ative colitis and Crohn's disease. A population-based study in Finland. J Crohns Colitis 2012; 6: 524-528 [PMID: 22398058 DOI: 10.1016/j.crohns.2011.10.009]
62. Romberg-Camps M, Kuiper E, Schouten L, Kester A, Hesselink-van de Kruijs M, Limonard C, Bos R, Goedhard J, Hameeteman W, Wolters F, Russel M, Stockbrügger R, Dagnelie P. Mortality in Inflammatory bowel disease in the Netherlands 1991-2002: results of a population-based study: the IBD South-Limburg cohort. Infamm Bowel Dis 2010; 16: 1397-1410 [PMID: 20027652 DOI: 10.1002/ibd.21189]
63. Jess T, Loftus EV, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ, Munkholm P, Sandborn WJ. Survival and cause specific mortality in patients with Inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 2006; 55: 1248-1254 [PMID: 16423890]
64. Hutfess SM, Weng X, Liu L, Allison J, Herrinton LJ. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003. Gastroenterology 2007; 133: 1779-1786 [PMID: 18054550]
65. Ha C, Ullman TA, Siegel CA, Kornbluth A. Patients enrolled in randomized controlled trials do not represent the infam-matory bowel disease patient population. Clin Gastroenterol Hepatol 2012; 10: 1002-1007 quiz e78 [PMID: 22343692 DOI: 10.1016/j.cgh.2012.02.004]